JP7874626B2 - 制御放出充填組成物およびそれを含むカプセル - Google Patents

制御放出充填組成物およびそれを含むカプセル

Info

Publication number
JP7874626B2
JP7874626B2 JP2023522950A JP2023522950A JP7874626B2 JP 7874626 B2 JP7874626 B2 JP 7874626B2 JP 2023522950 A JP2023522950 A JP 2023522950A JP 2023522950 A JP2023522950 A JP 2023522950A JP 7874626 B2 JP7874626 B2 JP 7874626B2
Authority
JP
Japan
Prior art keywords
capsule
release
controlled
composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023522950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023545494A (ja
JP2023545494A5 (cg-RX-API-DMAC7.html
Inventor
ファン、チー
スクル、カルナカール
Original Assignee
アール．ピー．シェーラー テクノロジーズ、エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アール．ピー．シェーラー テクノロジーズ、エルエルシー filed Critical アール．ピー．シェーラー テクノロジーズ、エルエルシー
Publication of JP2023545494A publication Critical patent/JP2023545494A/ja
Publication of JP2023545494A5 publication Critical patent/JP2023545494A5/ja
Application granted granted Critical
Publication of JP7874626B2 publication Critical patent/JP7874626B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023522950A 2020-10-16 2021-10-14 制御放出充填組成物およびそれを含むカプセル Active JP7874626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16
US63/092,679 2020-10-16
PCT/US2021/054991 WO2022081848A1 (en) 2020-10-16 2021-10-14 Controlled release fill compositions and capsules containing same

Publications (3)

Publication Number Publication Date
JP2023545494A JP2023545494A (ja) 2023-10-30
JP2023545494A5 JP2023545494A5 (cg-RX-API-DMAC7.html) 2024-10-16
JP7874626B2 true JP7874626B2 (ja) 2026-06-16

Family

ID=81209315

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023522950A Active JP7874626B2 (ja) 2020-10-16 2021-10-14 制御放出充填組成物およびそれを含むカプセル

Country Status (13)

Country Link
US (1) US20230372252A1 (cg-RX-API-DMAC7.html)
EP (1) EP4228608A4 (cg-RX-API-DMAC7.html)
JP (1) JP7874626B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230088730A (cg-RX-API-DMAC7.html)
CN (1) CN116367864A (cg-RX-API-DMAC7.html)
AR (1) AR123800A1 (cg-RX-API-DMAC7.html)
AU (2) AU2021360905B2 (cg-RX-API-DMAC7.html)
CA (1) CA3195386A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023005368A2 (cg-RX-API-DMAC7.html)
IL (1) IL301692A (cg-RX-API-DMAC7.html)
MX (1) MX2023004441A (cg-RX-API-DMAC7.html)
TW (1) TW202228655A (cg-RX-API-DMAC7.html)
WO (1) WO2022081848A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009536927A (ja) 2006-05-12 2009-10-22 オディディ，イサ 乱用可能性が低減された医薬組成物
JP2014528437A (ja) 2011-10-06 2014-10-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング オピオイドアゴニストおよびオピオイドアンタゴニストを含むタンパーレジスタント経口医薬剤形
JP2018515456A (ja) 2015-04-24 2018-06-14 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 粒子及び粉末から２種の薬物の急速放出をもたらすタンパレジスタントな固定用量組合せ
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5406530B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2978269A1 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009536927A (ja) 2006-05-12 2009-10-22 オディディ，イサ 乱用可能性が低減された医薬組成物
JP2014528437A (ja) 2011-10-06 2014-10-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング オピオイドアゴニストおよびオピオイドアンタゴニストを含むタンパーレジスタント経口医薬剤形
JP2018515456A (ja) 2015-04-24 2018-06-14 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 粒子及び粉末から２種の薬物の急速放出をもたらすタンパレジスタントな固定用量組合せ
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PARK, J.S., et al.，A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets，International Journal of Pharmaceutics，2010年，Vol.393，pp.79-87
RANE, M., et al.，Application of polyethylene oxide in hydrophilic matrix tablets，Pharma Times，2013年，Vol.45，pp.41-48

Also Published As

Publication number Publication date
IL301692A (en) 2023-05-01
US20230372252A1 (en) 2023-11-23
JP2023545494A (ja) 2023-10-30
AU2021360905A9 (en) 2024-10-10
KR20230088730A (ko) 2023-06-20
EP4228608A1 (en) 2023-08-23
NZ799086A (en) 2026-02-27
CO2023005368A2 (es) 2023-05-19
WO2022081848A1 (en) 2022-04-21
CA3195386A1 (en) 2022-04-21
AR123800A1 (es) 2023-01-11
AU2026201700A1 (en) 2026-03-26
AU2021360905A1 (en) 2023-06-01
EP4228608A4 (en) 2024-10-02
MX2023004441A (es) 2023-05-08
AU2021360905B2 (en) 2026-01-08
CN116367864A (zh) 2023-06-30
TW202228655A (zh) 2022-08-01

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241005

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241005

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250829

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260103

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260512

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260604

R150 Certificate of patent or registration of utility model

Ref document number: 7874626

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150